| Lipoproteins and Cardiovascular Health | Lifetime | 20 | US 12 | 99.85 |
| Acute Myocardial Infarction Research | Lifetime | 27 | US 17 | 99.89 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 21 | US 11 | 99.86 |
| Diabetes Treatment and Management | Lifetime | 113 | US 51 | 99.49 |
| Coronary Interventions and Diagnostics | Lifetime | 143 | US 69 | 99.52 |
| Pharmaceutical Economics and Policy | Lifetime | 54 | US 32 | 98.78 |
| Heart Failure Treatment and Management | Lifetime | 196 | US 105 | 99.22 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 488 | US 230 | 98.74 |
| Cardiac Imaging and Diagnostics | Lifetime | 891 | US 437 | 98.68 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 892 | US 355 | 97.81 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 912 | US 355 | 97.95 |
| Cancer, Lipids, and Metabolism | Lifetime | 688 | US 333 | 97.57 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 658 | US 273 | 97.90 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 779 | US 287 | 95.56 |
| Biomarkers in Disease Mechanisms | Lifetime | 217 | US 62 | 92.74 |
| GDF15 and Related Biomarkers | Lifetime | 282 | US 105 | 87.68 |
| Aortic Thrombus and Embolism | Lifetime | 667 | US 247 | 68.18 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 27 | US 13 | 99.42 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 30 | US 8 | 98.83 |
| Diabetes Treatment and Management | 2021-2025 | 99 | US 46 | 98.78 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 76 | US 26 | 97.49 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 104 | US 32 | 96.60 |
| Pancreatic function and diabetes | 2021-2025 | 316 | US 121 | 94.56 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 691 | US 230 | 95.55 |
| Acute Myocardial Infarction Research | 2021-2025 | 439 | US 105 | 94.78 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 296 | US 82 | 91.46 |
| Heart Failure Treatment and Management | 2021-2025 | 594 | US 191 | 93.07 |
| Lipid metabolism and disorders | 2021-2025 | 117 | US 35 | 88.07 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 280 | US 57 | 88.86 |
| Coronary Interventions and Diagnostics | 2021-2025 | 712 | US 151 | 92.53 |
| GDF15 and Related Biomarkers | 2021-2025 | 992 | US 239 | 39.83 |
| Macrophage Migration Inhibitory Factor | 2021-2025 | 634 | US 106 | 29.69 |
